Navigation Links
Prestigious fellowship for young Nottingham researcher
Date:2/3/2009

A promising young researcher at The University of Nottingham has been awarded a prestigious national fellowship to support her work investigating the molecular biology of hepatitis C virus.

Dr Catherine Jopling, of the University's School of Pharmacy, has received more than 1 million in funding over five years from a David Phillips fellowship given by the Biotechnology and Biological Sciences Research Council (BBSRC).

Dr Jopling said: "I'm delighted to have been awarded this fellowship. It will be enormously helpful in allowing me to set up my own group and to pursue this exciting research."

The fellowship will cover her salary and provide research funding to allow her to continue with work started while a postdoctoral researcher at Stanford University in the US looking at micro-RNAs, tiny molecules that play a major part in controlling gene expression in cells.

Dr Jopling's research focuses on miR-122, a specialised liver microRNA which interacts with hepatitis C virus (HCV) in an unusual way and plays an important role in helping the virus to replicate itself, an essential part of the viral life cycle.

Hepatitis C is a blood-borne infectious disease which currently affects around two per cent of the population. The infection can go undetected for a long period of time because it often produces no or few symptoms but as the disease becomes more chronic it can lead to serious scarring of the liver (cirrhosis) and even cancer.

Dr Jopling's research looking at how HCV hijacks miR122 to help in its attack on the liver has been recognised by the BBSRC because of the important role it plays in developing our understanding of gene expression and the basic biology of microRNA activity. In the future, the work may also have implications for medical advances if more can be understood about the process by which HCV replicates and spreads, new drugs which act by blocking this action could be developed to help halt the
'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
2. St. Marys Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
3. Accuray Receives Prestigious Awards for 2008 Advertising Campaign
4. Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program
5. Jerry Lewis to Receive Prestigious Award From Motion Picture Academy
6. Arthritis Foundation bestows prestigious national research award
7. Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence
8. Melissa Murer Corrigan Receives Prestigious NOCA Leadership Award
9. Capital BlueCross Receives Prestigious Corporation of the Year Award
10. U of T professor first Canadian woman to win prestigious international science prize
11. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... March 29, 2015 At this ... platform provides basic health information around medical conditions ... discuss these challenges as well as helping them ... addresses six medical conditions using evidenced based information ... engage in conversations around them., ...
(Date:3/28/2015)... March 28, 2015 Rocket Pure , ... announced the release of their new natural sunscreen. They ... ounce packages. Both options come with a bonus lip ... RocketPure.com or on Amazon. Click to see the ... that the natural sunscreen is made with non-nano zinc oxide ...
(Date:3/28/2015)... 2015 With more than 4,500 ... of osteoporosis, osteoarthritis and musculoskeletal diseases gathered here ... be the first time in the 17-year history ... the hot-button topic is an emerging non-pharmaceutical protocol ... scientific principles of Wolff’s law, osteogenic loading at ...
(Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... 2015 highlighted a problem which could prove critical to ... Why system testing, a critical aspect of data security, ... payment card industry data security report, every major category ... vulnerability scanning and penetration testing. “With all the craziness ...
(Date:3/28/2015)... Delaying rotator cuff surgery on patients with ... presented today at the American Orthopaedic Society for Sports ... compared results for 170 patients who received rotator cuff ... capsule release procedure to relieve stiffness at the time ... from St. George Hospital in Sydney, Australia. “Both groups ...
Breaking Medicine News(10 mins):Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2
... the past, it was thought that one of the selective ... the development of new behaviour to respond to the ecological ... a sudden reduction in food or the appearance of a ... and researcher at the Centre of Ecological Research and Forestry ...
... Today during the 88th General Session & Exhibition ... Barcelona, Spain, S. Offenbacher will present an abstract ... of Candidiasis-Associated Denture-Stomatitis." The goal of the ... in Candida albicans (a parasitic fungus that can ...
... of Orthopaedic Surgeons (AAOS) has approved and released an ... Joint Osteoarthritis." This major joint in the shoulder ... affected by osteoarthritis, causing pain, loss of function, and ... Rolando Izquierdo, MD, chair of the Academy work group ...
... By E.J. Mundell HealthDay Reporter , THURSDAY, ... Mary Cusack has been raising her son, Nicky, she,s become ... Nicky and others with autism often display. If left unchecked, ... and her husband, Tom, have found a solution to the ...
... conducting a clinical trial that targets malignant T-cell lymphoma, a ... affects the white blood cells that normally protect against illness, ... lymphomas are of B-cell origin, and 15% of T-cell origin. ... respond well to chemotherapy. Therefore, says Arthur ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, July 14 ... the risk of heart attack more than other medications of ... controls, a U.S. government advisory panel recommended late Wednesday. ... experts rejected the option that the U.S. Food and Drug ...
Cached Medicine News:Health News:The protective brain hypothesis is confirmed 2Health News:New research finds major activation themes in denture-stomatitis 2Health News:Shoulder arthritis? What patients need to know before treatment 2Health News:Shoulder arthritis? What patients need to know before treatment 3Health News:Gentle Horses Help Rein in Autism in Kids 2Health News:Gentle Horses Help Rein in Autism in Kids 3Health News:Gentle Horses Help Rein in Autism in Kids 4Health News:Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds 2Health News:Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds 3Health News:Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds 4
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
(Date:3/27/2015)... March 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... of its previously announced registered offering of common shares ... "Offering"). Pursuant to the Offering, the Company issued 7,286,432 ... for aggregate gross proceeds of approximately $1.45 billion. On ... Securities and Exchange Commission a final prospectus supplement to ...
(Date:3/27/2015)... , March 27, 2015 The International Myeloma ... myeloma patients while working toward prevention and a cure ... for introducing a federal resolution (H. Res. 174) that ... as "National Multiple Myeloma Awareness Month." Currently ... worldwide, and more than 110,000 new cases are diagnosed ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... Nov. 4 CVS Caremark (NYSE: CVS ) ... position of SVP, Marketing for its pharmacy benefit management ... marketing from Jack Bruner, who is transitioning to the ... http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO ) , Greer brings ...
... 4 Neuronascent, Inc., a privately-held biotechnology company ... of depression, Alzheimer,s disease, Parkinson,s and other neurodegenerative ... agreement with ChemRar Pharma, a Russian biotechnology start-up ... and stem cells to treat cancer. Under the ...
Cached Medicine Technology:Company Appoints New SVP, Marketing for PBM Business 2Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascent's Neurogenesis Platform 2
... Analyzer II is a ... to enumerate fluorescently labeled ... selected and aligned. The ... CellTracks® Analyzer II, a ...
... These unique Acid Fast ... sputum smear with appropriate background ... containing a positive and negative ... Kinyoun (Cat. No. 353), Ziehl-Neelsen ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Medicine Products: